Esperion Therapeutics, Inc. · NASDAQ:ESPR
Two Seas Capital LP reported a 5.00% stake in Esperion Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 13, 2025
Two Seas Capital LP reported a 5.00% stake in Esperion Therapeutics, Inc., 9,954,975 shares, as a passive investor on Jun 30, 2025. Filed Aug 13, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 9,954,975
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Two Seas Capital LP | 5.00% | 9,954,975 |
| Two Seas Capital GP LLC | 5.00% | 9,954,975 |
| Sina Toussi | 5.00% | 9,954,975 |
Source
Related
- Esperion Therapeutics, Inc.
- Two Seas Capital LP
- Esperion Therapeutics, Inc. shareholders
- Schedule 13G/A · Two Seas Capital LP · Nov 14, 2025
- Schedule 13G · Goldman Sachs Group Inc · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Wasatch Advisors LP · Jul 14, 2026
- Form 4 · Hoffman Robert E. · Jul 13, 2026
- Form 4 · Carroll J Martin · Jul 13, 2026